107 In vitro susceptibility of Pseudomonas aeruginosa (PA) does not predict clinical response to aztreonam 75 mg powder and solvent for nebuliser solution (AZLI): a responder analysis in subjects with cystic fibrosis (CF)

✍ Scribed by T. Pressler; B.M. Assael; R. Fischer; M. Bresnik; S. Lewis; M. McKevitt; A.B. Montgomery; C. Oermann

• Book ID: 118643015
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 48 KB
• Volume: 10
• Category: Article
• ISSN: 1569-1993
• DOI: 10.1016/s1569-1993(11)60124-0